Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small-Reference-Cited by-同舟云学术

Large Cell Neuroendocrine Prostate Cancer: Large Is Not Small

Published:2024-01-11 Issue:3 Volume:29 Page:185-189
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Serritella Anthony V¹^ORCID,Beltran Himisha²^ORCID,Lotan Tamara L³,VanderWeele David J¹,Karzai Fatima⁴,Madan Ravi A⁴^ORCID,Hussain Maha¹^ORCID

Affiliation:

1. Robert H. Lurie Comprehensive Cancer Center; Northwestern University Feinberg School of Medicine , Chicago, IL , USA

2. Dana-Farber Cancer Institute, Harvard Medical School , Boston, MA , USA

3. Department of Pathology, Department of Urology, Department of Oncology, Johns Hopkins University School of Medicine , Baltimore, MD , USA

4. Genitourinary Malignancies Branch Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA

Abstract

Neuroendocrine prostate cancer is complex, comprising a wide spectrum of phenotypes, which has led to very different entities being inappropriately lumped together or assumed to behave like more common entities. Elucidating subtle differences is critical for treatment decision making, as this commentary describes.

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/oncolo/article-pdf/29/3/185/56831514/oyad344.pdf

Reference41 articles.

1. Neuroendocrine prostate cancer: subtypes, biology,;Aggarwal,2014

2. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study;Aggarwal,2018

3. Deciphering the enigma of neuroendocrine prostate cancer;Karzai,2022

4. Therapy considerations in neuroendocrine prostate cancer: what next;Beltran,2021

5. Clinical features of neuroendocrine prostate cancer;Conteduca,2019